Financial News Archive

SEC EDGAR · Federal Reserve · FDA · BLS · Updated every 60s

Easterly
Easterly Government Properties reports Q3 2026 results

Easterly Government Properties announced Q3 2026 net income of $5.7 million and $38.0 million in Core FFO, largely driven by a stable government-lease...

NEWS
News Corp announces NWS Class A share buyback

News Corporation has updated its buy-back program for Class A stocks. The ASX-listed company re-notified the securities ticker NWS for a repurchase pr...

Vertiv
Vertiv completes acquisition of King Environmental Services Ltd.

Vertiv Holdings Co. completed the acquisition of KES to expand its thermal and fluid management services into Europe, Middle East and Africa. The deal...

KKR
KKR appoints Brian J. Lee to Board

KKR announced executive Brian J. Lee has been appointed to its Board of Directors as an independent member, effective October 26, 2026....

Braemar
Braemar Announces Slate of Independent Directors for 2026 Annual Meeting

Braemar Hotels & Resorts Inc. announced its Board intends to nominate eight highly qualified directors, including seven new ones, to be elected at the...

Climb
Budoprutug Phase 2 shows immunologic remission pMN

Climb Bio presented positive Phase 2 PrisMN data for budoprutug, showing B-cell depletion at 200 mg and supportive MCD case study results, while maint...

EQT
EQT to acquire Range Resources

EQT Corporation entered into an agreement to acquire Range Resources Corporation in a transaction valued at approximately $22.6 billion. The merger is...

13F-HR/A
13F-HR/A - Mason & Associates, LLC (0001895045) (Filer)

Institutional holdings report (13F-HR) for the period ended 2026-09-30 filed by 13F-HR/A - Mason & Associates, LLC (0001895045) (Filer)....

James
13F-HR - James Reed Financial Services, Inc. (0001911052) (Filer)

Institutional holdings report (13F-HR) for the period ended 2026-09-30 filed by James Reed Financial Services, Inc.....

MOTIVE
13F-HR - MOTIVE WEALTH ADVISORS (0001877093) (Filer)

Institutional holdings report (13F-HR) for the period ended 2026-09-30 filed by MOTIVE WEALTH ADVISORS....

Larry
13F-HR - Larry Mathis Financial Planning, LLC (0002118274) (Filer)

Institutional holdings report (13F-HR) for the period ended 2026-09-30 filed by Larry Mathis Financial Planning, LLC....

Leo
13F-HR - Leo Wealth, LLC (0001912202) (Filer)

Institutional holdings report (13F-HR) for the period ended 2026-09-30 filed by Leo Wealth, LLC....

Amanat
Amanat Acquisition to merge with Corxel Pharmaceuticals in business combination

Amanat Acquisition Corp. signed a definitive business combination agreement to merge with Corxel Pharmaceuticals, Inc. and Corxel Pharmaceuticals Limi...

Lakewood
13F-HR - Lakewood Asset Management LLC (0001966581) (Filer)

Institutional holdings report (13F-HR) for the period ended 2026-09-30 filed by Lakewood Asset Management LLC....

Davidson
13F-HR - Davidson Kahn Capital Management, LLC (0002055535) (Filer)

Institutional holdings report (13F-HR) for the period ended 2026-09-30 filed by Davidson Kahn Capital Management, LLC....

Game
Game Your Game Inc. Amends Warrant Exercise Price Order

Game Your Game Inc. confirmed a filing to amend a warrant issued by Streeterville Capital, LLC to lower the exercise price to $1.00 per share. This mo...

Artificial
AITX Defines Four Internal Breakeven Milestones

Artificial Intelligence Technology Solutions Inc. announced it will track progress toward financial self-sustainability through four internal operatin...

Oaktree
OAC extends third merger extension deadline to May 25, 2027

Oaktree Acquisition Corp. III Life Sciences has approved an amendment to its charter to extend the window for a business combination to the later of N...

Elme
Elme Communities Suspended NYSE Trading Ahead of OTC Transition

The NYSE delisted Elme Communities due to low trading prices and suspended shares immediately, with the stock expected to trade OTC on Monday, October...

ArriVent
MRI Announces Strong Initial Phase 1 Data for ARR-217 ADC ESMO

ArriVent BioPharma released initial encouraging Phase 1 data for the ARR-217 ADC showing a 44.8% ORR at 6mg/kg in colorectal cancer patients, generall...